Blueprint Neurotherapeutics Network

The Neurotherapeutics Grand Challenge 

Dr. Rajesh Ranganathan Explains the NIH Blueprint Neurotherapeutics Network
Watch Dr. Rajesh Ranganathan, Associate Director for Translational Research at NINDS, explain the NIH Blueprint and how the Blueprint Neurotherapeutics Network works.

Most nervous system disorders lack effective treatment, and most of the potential neurotherapeutic drugs identified in basic research do not make it to human testing:

The Blueprint Neurotherapeutics Network

The Blueprint Neurotherapeutics Network provides non-dilutive support for small molecule drug discovery and development, from hit-to-lead chemistry through phase I clinical testing. We offer funding for work that you wish to do yourself, access to NIH-funded contract research organizations (CROs) for activities that you prefer to outsource, and access to consultants with expertise in various aspects of drug discovery and development. You decide what combination of funding, CROs, and consultants will best fit your needs. Your institution gets assignment of the intellectual property rights to compounds discovered and developed within the program. 

View the listing of current projects in the Network.

(To view or print the PDF or Microsoft Word content on this page, download the free Adobe® Acrobat® Reader® or free Microsoft Word Viewer.)